Cargando…

Estimation of COVID-19 prevalence in Italy, Spain, and France

At the end of December 2019, coronavirus disease 2019 (COVID-19) appeared in Wuhan city, China. As of April 15, 2020, >1.9 million COVID-19 cases were confirmed worldwide, including >120,000 deaths. There is an urgent need to monitor and predict COVID-19 prevalence to control this spread more...

Descripción completa

Detalles Bibliográficos
Autor principal: Ceylan, Zeynep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175852/
https://www.ncbi.nlm.nih.gov/pubmed/32360907
http://dx.doi.org/10.1016/j.scitotenv.2020.138817
_version_ 1783524911170453504
author Ceylan, Zeynep
author_facet Ceylan, Zeynep
author_sort Ceylan, Zeynep
collection PubMed
description At the end of December 2019, coronavirus disease 2019 (COVID-19) appeared in Wuhan city, China. As of April 15, 2020, >1.9 million COVID-19 cases were confirmed worldwide, including >120,000 deaths. There is an urgent need to monitor and predict COVID-19 prevalence to control this spread more effectively. Time series models are significant in predicting the impact of the COVID-19 outbreak and taking the necessary measures to respond to this crisis. In this study, Auto-Regressive Integrated Moving Average (ARIMA) models were developed to predict the epidemiological trend of COVID-19 prevalence of Italy, Spain, and France, the most affected countries of Europe. The prevalence data of COVID-19 from 21 February 2020 to 15 April 2020 were collected from the World Health Organization website. Several ARIMA models were formulated with different ARIMA parameters. ARIMA (0,2,1), ARIMA (1,2,0), and ARIMA (0,2,1) models with the lowest MAPE values (4.7520, 5.8486, and 5.6335) were selected as the best models for Italy, Spain, and France, respectively. This study shows that ARIMA models are suitable for predicting the prevalence of COVID-19 in the future. The results of the analysis can shed light on understanding the trends of the outbreak and give an idea of the epidemiological stage of these regions. Besides, the prediction of COVID-19 prevalence trends of Italy, Spain, and France can help take precautions and policy formulation for this epidemic in other countries.
format Online
Article
Text
id pubmed-7175852
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71758522020-04-22 Estimation of COVID-19 prevalence in Italy, Spain, and France Ceylan, Zeynep Sci Total Environ Article At the end of December 2019, coronavirus disease 2019 (COVID-19) appeared in Wuhan city, China. As of April 15, 2020, >1.9 million COVID-19 cases were confirmed worldwide, including >120,000 deaths. There is an urgent need to monitor and predict COVID-19 prevalence to control this spread more effectively. Time series models are significant in predicting the impact of the COVID-19 outbreak and taking the necessary measures to respond to this crisis. In this study, Auto-Regressive Integrated Moving Average (ARIMA) models were developed to predict the epidemiological trend of COVID-19 prevalence of Italy, Spain, and France, the most affected countries of Europe. The prevalence data of COVID-19 from 21 February 2020 to 15 April 2020 were collected from the World Health Organization website. Several ARIMA models were formulated with different ARIMA parameters. ARIMA (0,2,1), ARIMA (1,2,0), and ARIMA (0,2,1) models with the lowest MAPE values (4.7520, 5.8486, and 5.6335) were selected as the best models for Italy, Spain, and France, respectively. This study shows that ARIMA models are suitable for predicting the prevalence of COVID-19 in the future. The results of the analysis can shed light on understanding the trends of the outbreak and give an idea of the epidemiological stage of these regions. Besides, the prediction of COVID-19 prevalence trends of Italy, Spain, and France can help take precautions and policy formulation for this epidemic in other countries. Elsevier B.V. 2020-08-10 2020-04-22 /pmc/articles/PMC7175852/ /pubmed/32360907 http://dx.doi.org/10.1016/j.scitotenv.2020.138817 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ceylan, Zeynep
Estimation of COVID-19 prevalence in Italy, Spain, and France
title Estimation of COVID-19 prevalence in Italy, Spain, and France
title_full Estimation of COVID-19 prevalence in Italy, Spain, and France
title_fullStr Estimation of COVID-19 prevalence in Italy, Spain, and France
title_full_unstemmed Estimation of COVID-19 prevalence in Italy, Spain, and France
title_short Estimation of COVID-19 prevalence in Italy, Spain, and France
title_sort estimation of covid-19 prevalence in italy, spain, and france
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175852/
https://www.ncbi.nlm.nih.gov/pubmed/32360907
http://dx.doi.org/10.1016/j.scitotenv.2020.138817
work_keys_str_mv AT ceylanzeynep estimationofcovid19prevalenceinitalyspainandfrance